A workshop on Bayesian adaptive randomised trials, delivered by international leaders in this field; Dr Lorenzo Trippa and Dr Steffen Ventz.
Update: This event is now sold-out. Please register for the wait-list to be notified if any tickets become available.Adaptive clinical trial designs have proven valuable to accelerate the development of new treatments. Adaptive randomisation based on Bayesian principles has been proposed for testing several treatments in complex clinical trials on heterogeneous populations. Recent applications suggest that outcome adaptive approaches can accelerate drug development processes. Adaptive algorithms attempt to learn and identify, during the trial, the best available treatment options for individual patients enrolled in the trial. We are pleased to present a workshop on Bayesian adaptive randomised trials, delivered by two international leaders in this field: Dr Lorenzo Trippa, PhD, is an Associate Professor with the Department of Biostatistics and Computational Biology at Dana-Farbern and the Department of Biostatistics at the Harvard T.H. Chan School of Public Health. Dr Steffen Ventz, PhD, is a research scientist with the Department of Data Sciences and the Center for Regulatory Sciences at the Dana-Farber Cancer Institute and the Department of Biostatistics at the Harvard T.H. Chan School of Public Health. This workshop is suitable for statisticians, clinicians and other scientists interested in innovative clinical trial designs and their analysis. Ideally delegates have an intermediate level of statistical expertise. Although not the main focus, the workshop involves practical sessions in R. Clinicians attending the workshop would ideally team up with a statistician during these sessions. Delegates should ensure that they have the R software installed in their laptops prior to attending the workshop. The workshops are being presented in association with VicBiostat and the Australian Trials Methodology Research Network (AusTriM).
Data and Safety Monitoring Boards Webinar Series: How to plan well and be prepared for the unexpected
Statistical Analysis Plan
What are the benefits of adaptive designs?
How do adaptive trial sizes work?
What is an adaptive clinical trial?
What is response adaptive randomisation?
Data Safety and Monitoring Boards (DSMB) for Adaptive Trials Webinar video
Data Safety and Monitoring Boards (DSMB) for Adaptive Trials Webinar slides
ACTA Trial of the Year Award 2020 guidelines and nomination forms
Bayesian adaptive randomised clinical trials flyer
ACTA STInG grant advice for trial statisticians
ACTA STInG Notes from Members’ meeting, October 2019
Adaptive Design Clinical Trials
Hackathon of Novel Trial Designs part two
Hackathon of Novel Trial Designs part one
Studies Within A Trial SWATs webinar
Innovative Trial Design and Conduct Reference Group Objectives and Directions
ACTA STInG 2017 Member Survey Results
Novel approaches to healthcare effectiveness research outside Australia
ACTA STInG Submission to the NHMRC Structural Review
Statistical principles – Data and Safety Monitoring Boards Webinar Series
How to plan well and be prepared for the unexpected – Data and Safety Monitoring Boards Webinar Series
Webinar: Data Safety and Monitoring Boards for Adaptive Trials
Bayesian Adaptive Randomised Clinical Trials Workshop, Melbourne
Bayesian Adaptive Trials Workshops: Perth
Workshop: Pragmatic randomised trial designs for evaluating health policy and practice change interventions